Written by Klarity Editorial Team
Published: Jul 12, 2026

Last updated: July 12, 2026
Presbyterian Health Plan is New Mexico’s largest regional health insurer and an integrated health system — combining insurance, provider networks, and pharmacy services under one roof. If you or a family member has ADHD and carries a Presbyterian Health Plan policy in New Mexico, understanding how your plan covers stimulant and non-stimulant medications, prior authorization requirements, and telehealth prescribing can save significant time and money.
This 2026 guide walks through Presbyterian Health Plan’s ADHD formulary structure, prior authorization (PA) processes, New Mexico’s mental health parity law, the Electronic Prescribing of Controlled Substances (EPCS) requirement, and how Klarity Health’s telehealth platform can connect you with a licensed New Mexico ADHD provider.
Verify your Presbyterian Health Plan ADHD benefits before your first appointment. Coverage details vary by plan type, employer group, and formulary year. See if you may qualify for ADHD treatment through Klarity Health — 2,000+ licensed providers, including those serving New Mexico patients.
Presbyterian Health Plan (PHP) is a subsidiary of Presbyterian Healthcare Services, a not-for-profit integrated health system headquartered in Albuquerque. Unlike national insurers, PHP is a New Mexico-specific plan with deep ties to the state’s provider and pharmacy infrastructure. PHP offers coverage across four major plan segments:
For ADHD treatment, the most relevant segments are large group, individual/small group, and Medicaid Turquoise Care. PHP administers a closed formulary, meaning only drugs listed on the formulary are covered without an exception process. Formulary decisions are made by PHP’s internal P&T Committee and may differ from national PBM formulary standards.
Presbyterian Health Plan uses a tiered formulary system for its commercial and exchange plans. Tier placement determines your out-of-pocket cost at the pharmacy. The general structure for ADHD medications follows patterns consistent with New Mexico’s insurance market, though specific tier assignments may vary by plan year and employer group. Always verify your specific benefit via myPRES (the PHP member portal) or by calling member services.
Stimulants are first-line pharmacotherapy for ADHD and are classified as Schedule II controlled substances by the DEA. Generic stimulants are typically well-covered under PHP formularies at lower tiers; brand-name stimulants typically require prior authorization and carry higher cost-sharing.
| Medication | Type | Typical Tier | PA Required? |
|---|---|---|---|
| Amphetamine/dextroamphetamine (generic Adderall) | Generic stimulant | Tier 1–2 | Typically no |
| Mixed amphetamine salts ER (generic Adderall XR) | Generic stimulant | Tier 2 | Typically no |
| Methylphenidate IR (generic Ritalin) | Generic stimulant | Tier 1–2 | Typically no |
| Methylphenidate ER (generic Concerta, Ritalin LA) | Generic stimulant | Tier 2 | Typically no |
| Dextroamphetamine (generic Dexedrine) | Generic stimulant | Tier 1–2 | Typically no |
| Lisdexamfetamine (generic Vyvanse) | Generic stimulant | Tier 2–3 | Verify with plan |
| Adderall XR (brand) | Brand stimulant | Tier 3–4 | Yes — PA required |
| Concerta (brand) | Brand stimulant | Tier 3–4 | Yes — PA required |
| Vyvanse (brand lisdexamfetamine) | Brand stimulant | Tier 3–4 | Yes — PA required |
| Focalin XR (brand dexmethylphenidate) | Brand stimulant | Tier 3–4 | Yes — PA required |
| Mydayis (brand) | Brand stimulant | Tier 3–4 | Yes — PA required |
| Jornay PM (brand) | Brand stimulant | Tier 3–4 | Yes — PA required |
Note: Generic lisdexamfetamine (generic Vyvanse) is now commercially available. Tier assignment and PA requirements for generic lisdexamfetamine may differ from the brand; verify your specific plan’s formulary position before assuming it follows the same PA criteria as the brand.
Non-stimulants are prescribed when stimulants cause intolerable side effects, are contraindicated, or when a patient or provider prefers a non-Schedule II approach. Non-stimulants are not controlled substances, which simplifies prescribing logistics considerably.
| Medication | Type | Typical Tier | PA Required? |
|---|---|---|---|
| Atomoxetine (generic Strattera) | Generic non-stimulant (SNRI) | Tier 2–3 | Typically no |
| Strattera (brand atomoxetine) | Brand non-stimulant | Tier 3–4 | Yes — step therapy |
| Guanfacine ER (generic Intuniv) | Generic alpha-2 agonist | Tier 1–2 | Typically no |
| Intuniv (brand guanfacine ER) | Brand alpha-2 agonist | Tier 3–4 | Yes — step therapy |
| Clonidine ER (generic Kapvay) | Generic alpha-2 agonist | Tier 1–2 | Typically no |
| Kapvay (brand clonidine ER) | Brand alpha-2 agonist | Tier 3–4 | Yes — step therapy |
| Qelbree (viloxazine ER) | Non-stimulant (SNRI-type) | Tier 3–4 | Yes — PA required |
Presbyterian Health Plan may require prior authorization for brand-name stimulants and certain non-stimulants before covering them at the preferred tier. A PA request typically involves your prescribing provider submitting documentation to PHP demonstrating medical necessity.
For ADHD stimulant PA, PHP’s criteria generally include:
PHP uses its SureScripts tool (available to contracted providers) to check whether pharmacy PA is required for a specific drug before submitting. Presbyterian providers submitting through the integrated system may find the PA process more streamlined than out-of-network providers.
PA timelines under NM law: Standard PA requests must receive a determination within 72 hours (or 3 business days). Urgent/expedited requests (when a delay would seriously jeopardize health) must be decided within 24 hours. If PA is denied, members have the right to appeal through PHP’s internal appeals process and, if still denied, through an independent external review.
PHP’s mail order pharmacy service — offered through Costco Mail Order — allows members to receive up to a 90-day supply of Tier 1, 2, and 3 medications, including non-stimulant ADHD medications. Stimulants (Schedule II) cannot be dispensed via mail order under federal law.
ADHD stimulants — including amphetamine salts, methylphenidate formulations, and lisdexamfetamine — are classified as Schedule II controlled substances by the DEA. Under New Mexico’s Electronic Prescribing of Controlled Substances rule (NMSA 1978 § 26-1-24 and associated regulations, implementing DEA EPCS standards under 21 CFR Part 1311), prescribers issuing Schedule II controlled substances must do so electronically.
At Klarity Health, all licensed New Mexico providers are EPCS-compliant. Electronic prescriptions are transmitted directly to your preferred pharmacy, satisfying the Schedule II EPCS requirement without requiring a paper prescription. This is an important practical consideration for patients who previously relied on paper prescriptions from in-person providers.
Non-stimulant ADHD medications (atomoxetine, guanfacine, clonidine, viloxazine) are not controlled substances. EPCS does not apply to them — they can be prescribed electronically or verbally, following standard non-controlled prescribing rules. Patients who choose non-stimulant treatment face no additional prescribing complexity from EPCS requirements.
New Mexico’s Mental Health Parity Act (NMSA 1978 § 59A-23E-19 et seq.) requires health insurers offering mental health and substance use disorder (MH/SUD) benefits to provide those benefits on terms no more restrictive than comparable medical or surgical benefits. For ADHD treatment, this means:
If you believe PHP has applied ADHD coverage restrictions that exceed those applied to comparable medical conditions, you may file a parity complaint with the New Mexico Office of Superintendent of Insurance (NM OSI) at 1-855-427-5674.
New Mexico’s state parity law applies to fully insured health plans regulated by the NM OSI — typically individual, small group, and fully insured large group plans. If your Presbyterian Health Plan coverage is through a self-funded employer plan (common at large employers), federal MHPAEA (29 U.S.C. § 1185a) governs parity, not state law. Self-funded plan disputes are filed with the U.S. Department of Labor. If you are unsure whether your employer plan is fully insured or self-funded, ask your HR department.
Klarity Health’s network includes 2,000+ licensed providers across the United States, including licensed New Mexico prescribers who can evaluate and treat ADHD via telehealth. A telehealth ADHD appointment with a Klarity provider typically includes:
Because PHP offers telehealth parity under New Mexico law, your telehealth visits with an in-network Klarity provider should be reimbursed at parity with equivalent in-person visits. Confirm in-network status by calling PHP member services or using the myPRES portal before booking.
Check whether you may qualify for ADHD treatment through Klarity Health — same-week appointments available with licensed New Mexico providers.
Before scheduling an ADHD evaluation, take the following steps to understand your out-of-pocket exposure:
Presbyterian Health Plan may cover ADHD medications for enrolled members with a documented medical necessity. Generic stimulants (amphetamine salts, methylphenidate formulations) are typically placed on lower formulary tiers with no PA requirement. Brand stimulants (Adderall XR, Vyvanse, Concerta) and brand non-stimulants typically require prior authorization and carry higher cost-sharing. Coverage varies by plan type — Medicaid Turquoise Care, large group, and exchange plans each have distinct formulary structures. Verify your specific benefits through myPRES or by calling 1-800-356-2219.
Brand stimulants such as Adderall XR and Vyvanse (brand lisdexamfetamine) typically require prior authorization under PHP’s formulary. PA criteria generally include a DSM-5 ADHD diagnosis and documentation of a trial of and inadequate response to a preferred generic stimulant. Generic lisdexamfetamine is now commercially available and may be placed on a lower tier — confirm current tier and PA requirements with PHP before prescribing or dispensing. Your Klarity provider can assist with PA documentation if required by your specific plan.
No. EPCS (Electronic Prescribing of Controlled Substances) applies only to Schedule II controlled substances. Non-stimulant ADHD medications — atomoxetine (generic Strattera), guanfacine ER (generic Intuniv), clonidine ER (generic Kapvay), and viloxazine (Qelbree) — are not controlled substances. They are not subject to EPCS requirements and can be prescribed via standard electronic or verbal prescription. Only stimulant ADHD medications (amphetamine salts, methylphenidate, dextroamphetamine, lisdexamfetamine) carry Schedule II status and therefore require EPCS-compliant prescribing in New Mexico.
NMSA 1978 § 59A-23E-19 et seq. requires PHP to provide mental health benefits — including ADHD treatment — on terms no more restrictive than comparable medical or surgical benefits. This means PHP may not impose stricter PA criteria, visit limits, or formulary tier restrictions on ADHD medications than it applies to comparable medical drugs. Telehealth ADHD visits must also be reimbursed at parity with in-person visits. If you believe a PHP coverage decision violates NM parity law, contact the NM OSI at 1-855-427-5674. Note: self-funded employer plans are governed by federal MHPAEA rather than state law.
Telehealth ADHD treatment may be covered under your Presbyterian Health Plan policy. New Mexico’s telehealth parity law requires that covered telehealth mental health services not carry greater cost-sharing or more restrictive benefit limits than equivalent in-person services. Klarity Health’s licensed New Mexico providers conduct ADHD evaluations and prescribe medications (including Schedule II stimulants via EPCS) through telehealth. Confirm in-network status and benefit details through myPRES or PHP member services at 1-800-356-2219 before booking.
Disclaimer: This article is for informational purposes only and does not constitute medical or insurance advice. ADHD medication coverage under Presbyterian Health Plan varies by plan type, employer group, formulary year, and individual member benefits. Coverage descriptions reflect general market patterns and may not reflect your specific plan’s current formulary. Always verify your benefits directly with Presbyterian Health Plan before scheduling an appointment or filling a prescription. Coverage status may change during the plan year.
Ready to explore ADHD treatment options in New Mexico? See if you may qualify through Klarity Health — 2,000+ licensed providers, EPCS-compliant prescribing, and same-week appointments available.
Find the right provider for your needs — select your state to find expert care near you.